A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg in partial fulfillment of the requirements for the degree of MSc (Dent) / A comparison of radiation doses to selected vital organs in the maxillo-facial region at three different settings on the Galileos cone-beam computed tomography (CBCT) machine in the Wits Dental Hospital, was conducted with the courtesy of the Department of Medical Physics of the Charlotte Maxeke Johannesburg Academic Hospital. The study made use of the RANDO phantom and TLD- 100 detector chips, which provided detailed mapping of the dose distribution from the Galileos CBCT machine. Sixty-two Sanford® lithium fluoride dosimeters- (TLD- 100) were irradiated using a calibrated known x-ray source after having undergone a recommended annealing cycle. The data showed great consistency in the results. Association between the different imaging modalities was further investigated using Kruskal-Wallis equality-of-populations rank test and Chi-squared test. A p-value of <0.05 was considered statistically significant. Since there do not appear to be major differences between the radiation doses for the different settings of the Galileos CBCT machine, the author recommends the use of the combined setting at all times for optimum image quality.

Degree of Master of Science in Dentistry by coursework and dissertation A research report submitted to the Faculty of Health Sciences, University of the Health Sciences. University of the Witwatersrand, Johannesburg, in partial fulfilment of the requirements for the degree of Master of Science in Dentistry Johannesburg, 2014 / Introduction: Dental Cone beam CT has encountered great success in diagnostics and treatment planning in dentistry. However, it makes use of ionizing radiation. Lots of concern on the effects of x-rays on vital organs of the head and neck region has been raised. Clarity on the amount of radiation received on these specific organs will be a contribution to a better use of the emergent technology. Aim: The aim of this study is to determine the potential dose of radiation received on the eye and thyroid and to quantify the amount of potential scatter on the gonads during CBCT examinations. Material and Methods: Calibrated Lithium- Fluoride thermoluminescent dosimeters were inserted inside an anthropomorphic phantom, on sites of the eye, thyroid and the gonads. After its submission to a CBCT examination, using the high and standard resolution for a similar scanning protocol, the dose of radiation received on each organ was calculated according to the ICRP guidelines. Results: An equivalent dose of 0.059 mGy was calculated for the eye. Compared to the threshold dose of 0.5 Gy fixed by the ICRP 2007, this can be considered as relatively low. The thyroid with an effective dose of 23.5 μSv represented 20% of the full body effective dose existing in literature. The gonads absorbed an effective dose of 0.05 μSv, which was considered as negligible. Conclusion: The doses calculated were considered as relatively low. However, dentists must be aware of risks of cumulative exposure. Therefore adherence to the ALARA principle and consideration of clinical indication for CBCT remain a priority.

No description available.

Absence of stearoyl-CoA desaturase-1 (SCD1) in mice leads to chronic inflammation of the skin and increased susceptibility to atherosclerosis, while also increasing plasma inflammatory markers. A recent report suggested that SCD1 deficiency also increases disease severity in a mouse model of inflammatory bowel disease, induced by dextran sulfate sodium (DSS). However, SCD1-deficient mice are known to consume increased amounts of water, which would also be expected to increase the intake of DSS-treated water. The aim of this study was to determine the effect of SCD1 deficiency on DSS-induced acute colitis with DSS dosing adjusted to account for genotype differences in fluid consumption. Wild-type controls were treated with 3.5% DSS for 5 days to induce moderately severe colitis, while the concentration of DSS given to SCD1-deficient mice was lowered to 2.5% to control for increased fluid consumption. Colonic inflammation was assessed by clinical and histological scoring. Although SCD1-deficient mice consumed a total intake of DSS that was greater than that of wild-type controls, colonic inflammation, colon length and fecal blood were not altered by SCD1-deficiency in DSS-induced colitis, while diarrhea and total weight loss were modestly improved. Despite SCD1 deficiency leading to chronic inflammation of the skin and increased susceptibility to atherosclerosis, it does not accelerate inflammation in the DSS-induced model of acute colitis when DSS intake is controlled. These observations suggest that SCD1 deficiency does not play a significant role in colonic inflammation in this model. [The original version of this article, along with updated information and services is located on the World Wide Web at: http://dx.doi.org/10.1016/j.bbalip.2009.08.001]

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2001. / Härtill 7 uppsatser.

No description available.

This dissertation presents novel sequential dose-finding designs that adjust for inter-individual pharmacokinetic variability in phase I cancer clinical trials. Unlike most traditional dose-finding designs whose primary goals are the determination of a maximum safe dose, the goal of our proposed designs is to estimate a patient-specific dosing function such that the responses of patients can achieve a target safety level. Extending from a single compartment model in the pharmacokinetic theory, we first postulate a linear model to describe the relationship between the area under concentration-time curve, dose and predicted clearance. We propose a repeated least squares procedure that aims to sequentially determine dose according to individual ability of metabolizing the drug. To guarantee consistent estimation of the individualized dosing function at the end of a trial, we apply repeated least squares subject to a consistency constraint based on an eigenvalue theory for stochastic linear regression. We empirically determine the convergence rate of the eigenvalue constraint using a real data set from an irinotecan study in colorectal carcinoma patients, and calibrate the procedure to minimize a loss function that accounts for the dosing costs of study subjects and future patients. When compared to the traditional body surface area and an equation based dosing methods, the simulation results demonstrate that the repeated least squares procedure control the dosing cost and allow for precise estimation of the dosing function. Furthermore, in order to enhance the generality and robustness of the dose-finding designs, we generalize the linear association to a nonlinear relationship between the response and a linear combination of dose and predicted clearance. We propose a two-stage sequential design, the semiparametric link-adapted recursion, which targets at individualizing dose assignments meanwhile adapting for an unknown nonlinear link function connecting the response and dose along with predicted clearance. The repeat least squares with eigenvalue constraint design is utilized as the first stage, and the second stage recursively applies an iterative semiparametric least squares approach to estimate the dosing function and determine dosage for next patient. The simulation results demonstrate that: at first, the performance of repeated least squares with eigenvalue constraint design is acceptably robust to model misspecifications; at second, as its performance is close to that of repeated least squares procedure under parametric models, the semiparametric link-adapted recursion does not sacrifice much estimation accuracy to gain robustness against model misspecifications; at last, compared to the repeated least squares procedure, the semiparametric link-adapted recursion can significantly improve the dosing costs and estimation precision under the semiparametric models.

Tn5 mutagenesis of apdA (for antibiotic production) and deletion of gacA (for global antibiotic and cyanide) resulted in the same pleiotropic phenotype in Pseudomonas fluorescens (i.e. production of an array of secondary metabolites including the antibiotics pyrrolnitrin, pyoluteorin, and 2,4-diacetylphloroglucinol as well as a tryptophan-side-chain oxidase, hydrogen cyanide, and an extracellular protease was abolished). The apdA and gacA loci were identified and cloned from the genome of Pf-5. Nucleotide sequencing of the apdA and gacA loci was used to identify the open reading frames for these genes. The deduced amino acid sequences for apdA and gacA exhibited similarity to sensor kinase (ApdA) and response regulator (GacA) proteins that comprise two-component regulatory systems. The C-terminal domain of GacA containing the putative helix-turn-helix DNA-binding motif was fused to the glutathione S-transferase protein. The glutathione S-transferase GacA C-terminal fusion protein was used in a cycle selection procedure that was designed to identify GacA binding sites from a complex pool of DNA fragments. Although a putative binding site for GacA was identified using the cycle selection procedure, the results were inconclusive due to several inconsistencies in the DNA-binding assay. The upstream region of one gene, which codes for a putative porin, was identified as a putative binding site for GacA by the cycle selection procedure. Studies initiated to determine whether gacA regulates transcription of this putative porin gene have been unsuccessful, so it remains unclear whether this gene is regulated by GacA. Also, asymptotic limits to biological control of Rhizoctonia damping-off of cotton were observed with the biological control agent P. fluorescens Pf-5. / Graduation date: 1999

Graduation date: 1999

No description available.